These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23147265)

  • 1. An association between -866G/A polymorphism in the promoter of UCP2 and obesity: a meta-analysis.
    Liu L; Zhao X; Kang S; Zhang D
    Gene; 2013 Feb; 514(1):41-7. PubMed ID: 23147265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UCP2 -866G/A, Ala55Val and UCP3 -55C/T polymorphisms in association with obesity susceptibility - a meta-analysis study.
    Qian L; Xu K; Xu X; Gu R; Liu X; Shan S; Yang T
    PLoS One; 2013; 8(4):e58939. PubMed ID: 23560041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCP2 -866G/A and Ala55Val, and UCP3 -55C/T polymorphisms in association with type 2 diabetes susceptibility: a meta-analysis study.
    Xu K; Zhang M; Cui D; Fu Y; Qian L; Gu R; Wang M; Shen C; Yu R; Yang T
    Diabetologia; 2011 Sep; 54(9):2315-24. PubMed ID: 21751002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequent UCP2 -866G>A polymorphism protects against insulin resistance and is associated with obesity: a study of obesity and related metabolic traits among 17 636 Danes.
    Andersen G; Dalgaard LT; Justesen JM; Anthonsen S; Nielsen T; Thørner LW; Witte D; Jørgensen T; Clausen JO; Lauritzen T; Holmkvist J; Hansen T; Pedersen O
    Int J Obes (Lond); 2013 Feb; 37(2):175-81. PubMed ID: 22349573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association of functional UCP2 -866G/A and Ala55Val polymorphisms and type 2 diabetes in the Chinese population based on a case-control study and a meta-analysis.
    Qin LJ; Wen J; Qu YL; Huang QY
    Genet Mol Res; 2013 Sep; 12(3):3324-34. PubMed ID: 24065674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between UCP1 -3826A/G, UCP2 -866G/A, Ala55Val and Ins/Del, and UCP3 -55C/T polymorphisms and susceptibility to type 2 diabetes mellitus: case-control study and meta-analysis.
    de Souza BM; Brondani LA; Bouças AP; Sortica DA; Kramer CK; Canani LH; Leitão CB; Crispim D
    PLoS One; 2013; 8(1):e54259. PubMed ID: 23365654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the UCP polymorphisms with susceptibility to obesity: case-control study and meta-analysis.
    Brondani LA; de Souza BM; Assmann TS; Bouças AP; Bauer AC; Canani LH; Crispim D
    Mol Biol Rep; 2014 Aug; 41(8):5053-67. PubMed ID: 24752406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnicity Differences in the Association of UCP1-3826A/G, UCP2-866G/A and Ala55Val, and UCP3-55C/T Polymorphisms with Type 2 Diabetes Mellitus Susceptibility: An Updated Meta-Analysis.
    Huang R; Cai T; Zhou Y; Wang Y; Wang H; Shen Z; Xia W; Liu X; Ding B; Luo Y; Yan R; Li H; Wu J; Ma J
    Biomed Res Int; 2021; 2021():3482879. PubMed ID: 34712730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis reveals the association of common variants in the uncoupling protein (UCP) 1-3 genes with body mass index variability.
    Brondani LA; Assmann TS; de Souza BM; Bouças AP; Canani LH; Crispim D
    PLoS One; 2014; 9(5):e96411. PubMed ID: 24804925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of the -866G/A UCP2 gene promoter polymorphism with type 2 diabetes and obesity in a Tehran population: a case control study.
    Heidari J; Akrami SM; Heshmat R; Amiri P; Fakhrzadeh H; Pajouhi M
    Arch Iran Med; 2010 Sep; 13(5):384-90. PubMed ID: 20804304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between the UCP2 -866 G>A polymorphism, diabetes, and beta-blocker use among patients with acute coronary syndromes.
    Beitelshees AL; Finck BN; Leone TC; Cresci S; Wu J; Province MA; Fabbrini E; Kirk E; Zineh I; Klein S; Spertus JA; Kelly DP
    Pharmacogenet Genomics; 2010 Apr; 20(4):231-8. PubMed ID: 20145583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study between the -866G/A polymorphism in the promoter of uncoupling protein-2 gene and polycystic ovary syndrome.
    Kim JH; Li L; Yun JH; Choi BC; Baek KH
    Mol Med Rep; 2011; 4(4):747-51. PubMed ID: 21584501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The common -866G/A polymorphism in the promoter region of the UCP-2 gene is associated with reduced risk of type 2 diabetes in Caucasians from Italy.
    Bulotta A; Ludovico O; Coco A; Di Paola R; Quattrone A; Carella M; Pellegrini F; Prudente S; Trischitta V
    J Clin Endocrinol Metab; 2005 Feb; 90(2):1176-80. PubMed ID: 15562023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncoupling protein 2 -866G/A and uncoupling protein 3 -55C/T polymorphisms in young South African Indian coronary artery disease patients.
    Phulukdaree A; Moodley D; Khan S; Chuturgoon AA
    Gene; 2013 Jul; 524(2):79-83. PubMed ID: 23639961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UCP2 and CFH Gene Variants with Genetic Susceptibility to Schizophrenia in Turkish Population.
    Nursal AF; Aydin PC; Pehlivan M; Sever U; Pehlivan S
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2084-2089. PubMed ID: 33191890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects.
    Sesti G; Cardellini M; Marini MA; Frontoni S; D'Adamo M; Del Guerra S; Lauro D; De Nicolais P; Sbraccia P; Del Prato S; Gambardella S; Federici M; Marchetti P; Lauro R
    Diabetes; 2003 May; 52(5):1280-3. PubMed ID: 12716765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis.
    Vogler S; Goedde R; Miterski B; Gold R; Kroner A; Koczan D; Zettl UK; Rieckmann P; Epplen JT; Ibrahim SM
    J Mol Med (Berl); 2005 Oct; 83(10):806-11. PubMed ID: 16021520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation.
    Salpea KD; Talmud PJ; Cooper JA; Maubaret CG; Stephens JW; Abelak K; Humphries SE
    Atherosclerosis; 2010 Mar; 209(1):42-50. PubMed ID: 19889414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uncoupling protein 2 promoter polymorphism -866G/A affects its expression in beta-cells and modulates clinical profiles of Japanese type 2 diabetic patients.
    Sasahara M; Nishi M; Kawashima H; Ueda K; Sakagashira S; Furuta H; Matsumoto E; Hanabusa T; Sasaki H; Nanjo K
    Diabetes; 2004 Feb; 53(2):482-5. PubMed ID: 14747301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple and rapid detection of uncoupling protein-2 - 866G/A polymorphism by mutagenically separated polymerase chain reaction.
    Zhang B; Tanaka H; Saku K
    Clin Chim Acta; 2004 Jun; 344(1-2):205-10. PubMed ID: 15149891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.